pentetic acid has been researched along with Adenoma, alpha-Cell in 5 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of the 60 evaluable patients, 51 had carcinoid tumours, 3 gastrinomas, 2 glucagonomas, 1 insulinoma and 3 paragangliomas." | 1.33 | Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours. ( Arnold, R; Bauhofer, A; Béhé, MP; Behr, TM; Gotthardt, M; Grass, J; Kalinowski, M; Oyen, WJ; Rinke, A; Schipper, ML, 2006) |
| "In this report, imaging of a glucagonoma with In-111 DTPA-D-PHE1 octreotide scintigraphy is described in a 51-year-old woman examined for a large palpable abdominal mass." | 1.31 | Current imaging and possible therapeutic management of glucagonoma tumors: a case report. ( Bornemann, M; Coel, MN; Johnson, DS, 2000) |
| "Primary cultures of gastric carcinoid, midgut carcinoid and glucagonoma cells were incubated with 111In-DTPA-D-Phe1-octreotide and cell-surface bound, internalized and released 111In activity was measured." | 1.29 | Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. ( Ahlman, H; Andersson, P; Fjälling, M; Forssell-Aronsson, E; Johanson, V; Nilsson, O; Wängberg, B, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotthardt, M | 1 |
| Béhé, MP | 1 |
| Grass, J | 1 |
| Bauhofer, A | 1 |
| Rinke, A | 1 |
| Schipper, ML | 1 |
| Kalinowski, M | 1 |
| Arnold, R | 1 |
| Oyen, WJ | 1 |
| Behr, TM | 1 |
| Krenning, EP | 1 |
| Kooij, PP | 1 |
| Bakker, WH | 1 |
| Breeman, WA | 1 |
| Postema, PT | 1 |
| Kwekkeboom, DJ | 1 |
| Oei, HY | 1 |
| de Jong, M | 1 |
| Visser, TJ | 1 |
| Reijs, AE | 1 |
| Yamamoto, K | 1 |
| Ishii, Y | 1 |
| Furudate, M | 1 |
| Ito, K | 1 |
| Tsukamoto, E | 1 |
| Kanamaru, R | 1 |
| Endo, K | 1 |
| Hirano, T | 1 |
| Tanaka, K | 1 |
| Ogino, Y | 1 |
| Andersson, P | 1 |
| Forssell-Aronsson, E | 1 |
| Johanson, V | 1 |
| Wängberg, B | 1 |
| Nilsson, O | 1 |
| Fjälling, M | 1 |
| Ahlman, H | 1 |
| Johnson, DS | 1 |
| Coel, MN | 1 |
| Bornemann, M | 1 |
1 trial available for pentetic acid and Adenoma, alpha-Cell
| Article | Year |
|---|---|
[Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors].
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrinoma; Glucagonoma; Humans; Indium Radioisotopes; Insulin | 1995 |
4 other studies available for pentetic acid and Adenoma, alpha-Cell
| Article | Year |
|---|---|
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Glucagonoma; Humans; Indium Radioisot | 2006 |
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Topics: Female; Follow-Up Studies; Glucagonoma; Humans; Indium Radioisotopes; Liver Neoplasms; Middle Aged; | 1994 |
Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
Topics: Autoradiography; Carcinoid Tumor; Gastrointestinal Neoplasms; Glucagonoma; Humans; Indium Radioisoto | 1996 |
Current imaging and possible therapeutic management of glucagonoma tumors: a case report.
Topics: Female; Glucagonoma; Humans; Indium Radioisotopes; Middle Aged; Octreotide; Pancreatic Neoplasms; Pe | 2000 |